Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 4/2016

Open Access 01-04-2016 | Original Article

A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency

Authors: Simone Punt, Emilie A. C. Dronkers, Marij J. P. Welters, Renske Goedemans, Senada Koljenović, Elisabeth Bloemena, Peter J. F. Snijders, Arko Gorter, Sjoerd H. van der Burg, Robert J. Baatenburg de Jong, Ekaterina S. Jordanova

Published in: Cancer Immunology, Immunotherapy | Issue 4/2016

Login to get access

Abstract

Patients with HPV-positive oropharyngeal squamous cell carcinomas (OPSCCs) have a better prognosis than patients with non-HPV-induced OPSCC. The role of the immune response in this phenomenon is yet unclear. We studied the number of T cells, regulatory T cells (Tregs), T helper 17 (Th17) cells and IL-17+ non-T cells (mainly granulocytes) in matched HPV-positive and HPV-negative OPSCC cases (n = 162). Furthermore, the production of IFN-γ and IL-17 by tumor-infiltrating T cells was analyzed. The number of tumor-infiltrating T cells and Tregs was higher in HPV-positive than HPV-negative OPSCC (p < 0.0001). In contrast, HPV-negative OPSCC contained significantly higher numbers of IL-17+ non-T cells (p < 0.0001). Although a high number of intra-tumoral T cells showed a trend toward improved survival of all OPSCC patients, their prognostic effect in patients with a low number of intra-tumoral IL-17+ non-T cells was significant with regard to disease-specific (p = 0.033) and disease-free survival (p = 0.012). This suggests that a high frequency of IL-17+ non-T cells was related to a poor immune response, which was further supported by the observation that a high number of T cells was correlated with improved disease-free survival in the HPV-positive OPSCC (p = 0.008). In addition, we detected a minor Th17 cell population. However, T cells obtained from HPV-positive OPSCC produced significantly more IL-17 than those from HPV-negative tumors (p = 0.006). The improved prognosis of HPV-positive OPSCC is thus correlated with higher numbers of tumor-infiltrating T cells, more active Th17 cells and lower numbers of IL-17+ non-T cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pezzuto F, Buonaguro L, Caponigro F, Ionna F, Starita N, Annunziata C et al (2015) Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies. Oncology 89:125–136. doi:10.1159/000381717 CrossRefPubMed Pezzuto F, Buonaguro L, Caponigro F, Ionna F, Starita N, Annunziata C et al (2015) Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies. Oncology 89:125–136. doi:10.​1159/​000381717 CrossRefPubMed
2.
go back to reference van Monsjou HS, van Velthuysen ML, van den Brekel MW, Jordanova ES, Melief CJ, Balm AJ (2012) Human papillomavirus status in young patients with head and neck squamous cell carcinoma. Int J Cancer 130:1806–1812. doi:10.1002/ijc.26195 CrossRefPubMed van Monsjou HS, van Velthuysen ML, van den Brekel MW, Jordanova ES, Melief CJ, Balm AJ (2012) Human papillomavirus status in young patients with head and neck squamous cell carcinoma. Int J Cancer 130:1806–1812. doi:10.​1002/​ijc.​26195 CrossRefPubMed
5.
go back to reference Rietbergen MM, Leemans CR, Bloemena E, Heideman DA, Braakhuis BJ, Hesselink AT et al (2013) Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 132:1565–1571. doi:10.1002/ijc.27821 CrossRefPubMed Rietbergen MM, Leemans CR, Bloemena E, Heideman DA, Braakhuis BJ, Hesselink AT et al (2013) Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 132:1565–1571. doi:10.​1002/​ijc.​27821 CrossRefPubMed
9.
go back to reference Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R et al (2006) High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 24:5630–5636. doi:10.1200/JCO.2005.04.6136 CrossRefPubMed Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R et al (2006) High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 24:5630–5636. doi:10.​1200/​JCO.​2005.​04.​6136 CrossRefPubMed
10.
go back to reference Rietbergen MM, Brakenhoff RH, Bloemena E, Witte BI, Snijders PJ, Heideman DA et al (2013) Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. Ann Oncol 24:2740–2745. doi:10.1093/annonc/mdt319 CrossRefPubMed Rietbergen MM, Brakenhoff RH, Bloemena E, Witte BI, Snijders PJ, Heideman DA et al (2013) Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. Ann Oncol 24:2740–2745. doi:10.​1093/​annonc/​mdt319 CrossRefPubMed
12.
go back to reference Tinhofer I, Johrens K, Keilholz U, Kaufmann A, Lehmann A, Weichert W et al (2015) Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence. Eur J Cancer 51:514–521. doi:10.1016/j.ejca.2014.12.018 CrossRefPubMed Tinhofer I, Johrens K, Keilholz U, Kaufmann A, Lehmann A, Weichert W et al (2015) Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence. Eur J Cancer 51:514–521. doi:10.​1016/​j.​ejca.​2014.​12.​018 CrossRefPubMed
18.
go back to reference Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS et al (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25:2586–2593. doi:10.1200/JCO.2006.09.4565 CrossRefPubMed Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS et al (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25:2586–2593. doi:10.​1200/​JCO.​2006.​09.​4565 CrossRefPubMed
19.
go back to reference Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942–949. doi:10.1038/nm1093 CrossRefPubMed Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942–949. doi:10.​1038/​nm1093 CrossRefPubMed
20.
22.
go back to reference Cunha LL, Morari EC, Guihen AC, Razolli D, Gerhard R, Nonogaki S et al (2012) Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 77:918–925. doi:10.1111/j.1365-2265.2012.04482.x CrossRef Cunha LL, Morari EC, Guihen AC, Razolli D, Gerhard R, Nonogaki S et al (2012) Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 77:918–925. doi:10.​1111/​j.​1365-2265.​2012.​04482.​x CrossRef
23.
24.
28.
go back to reference Hesselink AT, Berkhof J, van der Salm ML, van Splunter AP, Geelen TH, van Kemenade FJ et al (2014) Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region. J Clin Microbiol 52:890–896. doi:10.1128/JCM.03195-13 CrossRefPubMedPubMedCentral Hesselink AT, Berkhof J, van der Salm ML, van Splunter AP, Geelen TH, van Kemenade FJ et al (2014) Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region. J Clin Microbiol 52:890–896. doi:10.​1128/​JCM.​03195-13 CrossRefPubMedPubMedCentral
31.
go back to reference Rietbergen MM, Witte BI, Velazquez ER, Snijders PJ, Bloemena E, Speel EJ et al (2015) Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe. Br J Cancer 112(11):1733–1736. doi:10.1038/bjc.2015.139 CrossRefPubMed Rietbergen MM, Witte BI, Velazquez ER, Snijders PJ, Bloemena E, Speel EJ et al (2015) Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe. Br J Cancer 112(11):1733–1736. doi:10.​1038/​bjc.​2015.​139 CrossRefPubMed
35.
go back to reference Krupar R, Robold K, Gaag D, Spanier G, Kreutz M, Renner K et al (2014) Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different. Virchows Arch 465:299–312. doi:10.1007/s00428-014-1630-6 CrossRefPubMed Krupar R, Robold K, Gaag D, Spanier G, Kreutz M, Renner K et al (2014) Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different. Virchows Arch 465:299–312. doi:10.​1007/​s00428-014-1630-6 CrossRefPubMed
36.
go back to reference Turksma AW, Bontkes HJ, van den Heuvel H, de Gruijl TD, von Blomberg BM, Braakhuis BJ et al (2013) Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients. Oral Dis 19(6):577–584. doi:10.1111/odi.12037 CrossRefPubMed Turksma AW, Bontkes HJ, van den Heuvel H, de Gruijl TD, von Blomberg BM, Braakhuis BJ et al (2013) Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients. Oral Dis 19(6):577–584. doi:10.​1111/​odi.​12037 CrossRefPubMed
38.
go back to reference Nordfors C, Grun N, Tertipis N, Ahrlund-Richter A, Haeggblom L, Sivars L et al (2013) CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. Eur J Cancer 49:2522–2530. doi:10.1016/j.ejca.2013.03.019 CrossRefPubMed Nordfors C, Grun N, Tertipis N, Ahrlund-Richter A, Haeggblom L, Sivars L et al (2013) CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. Eur J Cancer 49:2522–2530. doi:10.​1016/​j.​ejca.​2013.​03.​019 CrossRefPubMed
39.
go back to reference Piersma SJ, Jordanova ES, van Poelgeest MI, Kwappenberg KM, van der Hulst JM, Drijfhout JW et al (2007) High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res 67:354–361. doi:10.1158/0008-5472.CAN-06-3388 CrossRefPubMed Piersma SJ, Jordanova ES, van Poelgeest MI, Kwappenberg KM, van der Hulst JM, Drijfhout JW et al (2007) High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res 67:354–361. doi:10.​1158/​0008-5472.​CAN-06-3388 CrossRefPubMed
40.
go back to reference Jordanova ES, Gorter A, Ayachi O, Prins F, Durrant LG, Kenter GG et al (2008) Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8 +/regulatory T-cell ratio: which variable determines survival of cervical cancer patients? Clin Cancer Res 14:2028–2035. doi:10.1158/1078-0432.CCR-07-4554 CrossRefPubMed Jordanova ES, Gorter A, Ayachi O, Prins F, Durrant LG, Kenter GG et al (2008) Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8 +/regulatory T-cell ratio: which variable determines survival of cervical cancer patients? Clin Cancer Res 14:2028–2035. doi:10.​1158/​1078-0432.​CCR-07-4554 CrossRefPubMed
Metadata
Title
A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency
Authors
Simone Punt
Emilie A. C. Dronkers
Marij J. P. Welters
Renske Goedemans
Senada Koljenović
Elisabeth Bloemena
Peter J. F. Snijders
Arko Gorter
Sjoerd H. van der Burg
Robert J. Baatenburg de Jong
Ekaterina S. Jordanova
Publication date
01-04-2016
Publisher
Springer Berlin Heidelberg
Published in
Cancer Immunology, Immunotherapy / Issue 4/2016
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-016-1805-x

Other articles of this Issue 4/2016

Cancer Immunology, Immunotherapy 4/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine